BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gole B, Potočnik U. Pre-Treatment Biomarkers of Anti-Tumour Necrosis Factor Therapy Response in Crohn's Disease-A Systematic Review and Gene Ontology Analysis. Cells 2019;8:E515. [PMID: 31141991 DOI: 10.3390/cells8060515] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Safari S, Rostami-Nejad M, Rezaei-Tavirani M, Mansouri V, Razzaghi Z, Rezaei-Tavirani M. Assessment of Dysregulation of HERC6 and Essential Biological Processes in Response to Laser Therapy of Human Arm Skin. J Lasers Med Sci 2020;11:115-9. [PMID: 32273950 DOI: 10.34172/jlms.2020.20] [Reference Citation Analysis]
2 Wu KC, Lee DY, Hsu JT, Cheng CF, Lan JL, Chiu SC, Cho DY, Hsu JL. Evaluations and Mechanistic Interrogation of Natural Products Isolated From Paeonia suffruticosa for the Treatment of Inflammatory Bowel Disease. Front Pharmacol 2021;12:696158. [PMID: 34938175 DOI: 10.3389/fphar.2021.696158] [Reference Citation Analysis]
3 Gorenjak M, Zupin M, Jezernik G, Skok P, Potočnik U. Omics data integration identifies ELOVL7 and MMD gene regions as novel loci for adalimumab response in patients with Crohn's disease. Sci Rep 2021;11:5449. [PMID: 33750834 DOI: 10.1038/s41598-021-84909-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Mahajna H, Ben-Horin S. Novel bio-genetic predictors of response to biologic treatment in inflammatory bowel diseases. Curr Opin Pharmacol 2020;55:132-40. [PMID: 33249396 DOI: 10.1016/j.coph.2020.10.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Cui G, Fan Q, Li Z, Goll R, Florholmen J. Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers. EBioMedicine 2021;66:103329. [PMID: 33862588 DOI: 10.1016/j.ebiom.2021.103329] [Reference Citation Analysis]
6 Peyrin-Biroulet L, Sandborn WJ, Panaccione R, Domènech E, Pouillon L, Siegmund B, Danese S, Ghosh S. Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues. Therap Adv Gastroenterol 2021;14:17562848211059954. [PMID: 34917173 DOI: 10.1177/17562848211059954] [Reference Citation Analysis]